The outlook for patients with follicular lymphoma is becoming increasingly bright. Some long-term studies show that many patients may not require treatment for a very long time. And even when the "watch and wait" period ends, the therapies available are becoming much more tolerable, with lower toxicity and fewer side effects. We got an update on the research from lymphoma expert Dr. Marinus van Oers at the 9th European Congress on Hematologic Malignancies in Lyon, France.

Loading more stuff…

Hmm…it looks like things are taking a while to load. Try again?

Loading videos…